Articles for Nathan Geffen
Ivermectin: balance of evidence shows no benefit against Covid-19
While it’s too soon to say that the drug is useless, it has clearly been overhyped
By Nathan Geffen and Elsabé Brits
Science | 5 July 2021
The EFF wants us to use the Russian and Chinese vaccines. But there are unanswered questions about them
The regulatory authority must act in the public interest and not be swayed by undue pressure
By Nathan Geffen and Michael Cherry
Science | 23 June 2021
One week of Covid vaccines: What are we doing well? What can be done better?
An assessment of the rollout so far
By Nathan Geffen and Marcus Low
Analysis | 24 May 2021
Why should South Africans care about Israel’s apartheid?
“We recognise apartheid when we see it” say South African Jews
By James Stent and Nathan Geffen
Analysis | 21 May 2021
How to vaccinate millions as quickly as possible
Don’t try to micromanage the rollout
By Nathan Geffen and Marcus Low
Opinion | 14 May 2021
In photos: the grim aftermath of Cape Town’s fire
Flames destroy buildings, monuments and precious archives
By Ashraf Hendricks, James Stent and Nathan Geffen
Photo | 19 April 2021
This is how South Africa’s vaccination programme works. But is the system able to scale up?
Getting vaccinated “is the best thing you can do for yourself” says Groote Schuur nurse
By Elsabé Brits and Nathan Geffen
News | 17 March 2021
Covid-19: Remarkable results from blood donor survey
For the four provinces analysed, over half the population has likely had a SARS-CoV-2 infection
By Michael Cherry and Nathan Geffen
Science | 13 February 2021
Covid-19: Ivermectin obsession is dangerous
A court case brought by Afriforum risks undermining the scientific governance of medicine
Opinion | 29 January 2021